Two experiments were conducted at three locations to determine the correct dosage and carrier for trenbolone acetate (TBA) and estradiol (E2) implants in feedlot steers. In the dose-response experiment, 1,296 steers were allotted to six implant treatments and feed efficiency by 10% (P c .001) over control and 10% ( P e .0011 and 7% ( P < .01) over E2 alone, respectively. In the carrier experiment, all implant treatments increased steer performance over control ( P < .011; no differences in response were observed ( P > .2) between LA and CH carriers or between 28 and 20 mg of E2 in combination with 140 mg of TBA. Implant treatments, in general, decreased ( P < .05) carcass fatness and quality grade; little difference was noted in carcass characteristics between E2 alone and treatments containing TBA. Combinations of TBA/E2 were more effective enhancers of steer performance under U.S. conditions than was either E2 or TBA alone (Exp. 11, and combinations were similar to SS-reimplanted (Exp. 2).
Introduction
Trenbolone acetate (TBA) is a potent synthetic analog of testosterone (Velluz et al., 1967) ; it is thought to act on skeletal muscle, either through androgen receptors to increase protein synthesis ' J. Anim. Sci. 1992 Sci. . 70:1326 Sci. -1332 or through glucocorticoid receptors to reduce the catabolic effects of glucocorticoids (Muir, 1985) . In other parts of the world, TBA/estradiol (Ez) combinations (Grandadam et al., 1975) are used to promote growth in cattle. Beef production in the United States often differs from that in other countries in type and sex (steers) of cattle and the use of high-grain diets. A 5:l ratio of TBA and E2
seems to be optimal for growth promotion in steers under U.S. conditions IR. J. Grant, unpublished data), but the proper dosage has not been defined. A carrier matrix must deliver the anabolic agent at a level adequate for maximum response during the life of the implant. Previous TBA implants used a lactose-based matrix and had an estimated effective life of 60 to 80 d. Cholesterol (CHI may release the anabolic agent at a slower rate than lactose (LA; Istasse et al., 1988) . Two experiments were conducted to compare CH and LA carriers and to determine the optimum dosage of TBA/E2 implants for finishing steers (growth and carcass characteristics) under U.S. feedlot conditions.
Experimental Procedures

Dose-Response Experiment
The experiment was conducted at three locations (private research facilities in Colorado and Nebraska, and a t Texas Tech University [TTUI) as part of a petition to the Food and Drug Administration for product approval. At each location, crossbred steers (320 kg; Colorado: British x Continental; Nebraska: British; Texas: British x Brahman) were purchased and received typical feedlot processing upon arrival. After a receiving period, experimental steers (336 at TTU and 480 at the Colorado and Nebraska locations) were selected based on health and weight uniformity. Steers were stratified by weight into eight weight blocks and were assigned randomly to pens within block. Six implant treatments were assigned randomly to eight pens per location: control, 140 (NRC, 1984) diets starting with a medium-energy diet followed by a high-energy finishing diet. No ionophores or other feed additives were used. Compositions of the finishing diets are shown in Table 1 .
Locations differed somewhat in experimental conditions, including dietary ingredients (Table 11 , number of steers per pen (7 or 101, and type of pen. In Colorado and Nebraska, the floor of the pen was soil and there was at least 12 m2 of space per steer. In Texas, pens had partially slotted, concrete floors and provided 2.25 m2 of space per animal. Steers were slaughtered after 140 to 160 d on feed. Liver abscess incidence was recorded at slaughter at the Colorado and Texas locations. Carcass longissimus muscle area and backfat thickness were determined and marbling and kidney-pelvic-heart fat (KPH) were estimated after overnight chilling of the carcasses.
The variances among locations were tested for homogeneity at P = .005 for each trait. Bartlett's test (Gill, 1978) was computed and the unweighted analysis of variance was deemed appropriate for ADG and feed efficiency. A weighted analysis, however, was required for carcass marbling score and backfat thickness.
Implant treatment effects on steer performance and carcass characteristics were computed and evaluated using the GLM procedure (SAS, 1985) . Pen was the experimental unit. The model included implant treatment (six treatments), location, and their interaction as sources of variation; estradiol alone (0/301 and TBA alone (140/0) were compared to the unimplanted controls and to the highest dosage (140/28). To determine the optimum dosages for growth and efficiency improvement (control, 20/4, 80/16 , and 140/28 treatments were used), the nonlinear regression (NLIN) procedure of SAS was used to fit a quadratic model with plateau (y = a + bx + cx2; segmented model).
Because determination of the optimum dosage also requires comparisons of individual dosages (to determine whether two dosages cause similar or different responses), the four dosages also were evaluated using the GLM procedure and the means were evaluated using the lsd procedure. If the interaction between location and treatment was significant ( P c 21, it was used to test treatment differences. If the interaction term was BARTLE not significant (P > .2), it was removed and the reduced model was used.
Carrier Experiment
The same three locations and general protocol were used as in the dose-response experiment. The major differences were that there were eight instead of 10 steers per pen a t the Colorado and Nebraska locations and there were five instead of eight weight blocks for a total of 575 steers. Liver abscess incidence was recorded a t the Texas location only.
Five implant treatments were assigned to five Table 2 ). No ionophores or other feed additives were used. Performance results from the three locations were pooled after evaluation of location variances as in the dose-response experiment. Implant treatment effects on steer performance (d 0 to 70 and d ET AL.
0 to slaughter) and carcass characteristics were evaluated using ANOVA procedures. The model included implant treatment, location, and their interaction as the sources of variation. Pen was the experimental unit; treatment means were separated using the lsd test.
Results and Discussion
Dose-Response Experiment
The effects of implant treatment on steer performance and DMI are presented in Table 3 . The F-values had probabilities e .05 for all variables. As expected, the SE for the six and four treatment comparisons were essentially identical; the six treatment SE therefore are shown in the tables. A location x implant interaction was observed for ADG (P = .09) and feed efficiency (P e .0011. Therefore, the interaction term was retained in the model and it was used to test implant treatment differences. At the Colorado location, the ADG response was higher for 140/0 than for control (1.52 vs 1.46 kgl; at the Texas location, the 140/0 response was less than control (.92 vs .95 kgl, and at the Nebraska location the two treatments had equal ADG (1.46 kgl. In the Colorado and Nebraska experiments, feed efficiency response was greater for 140/0 than for control and better for 20/4 than for 0/30. In Texas, however, these treatment differences were reversed. The reason for this location x treatment interaction is not clear.
Averaged across locations, E2 alone (0/30) increased ADG by 7% (1.38 vs 1.29 kg, P < .01) and tended to improve feed efficiency (3%, P = .17) compared with control. The 7% growth response to E2 alone (0/301 is somewhat less than that usually reported, including other studies with TBA (Combs and Hinman, 1985; Trenkle, 1987) . The duration of this experiment, however, was longer than the typical life of a n E2 implant. Trenbolone acetate alone (140/0) did not improve ADG or feed efficiency (P > .2) over control, which agrees with reports by Combs and Hinman (1985) and Hunt et al. (1991) but is in contrast to the summary by Trenkle (19871. The lowest TBA/E2 combination (20/4) .2) in percentage Choice. This marbling score difference reflects the biological effects of the TBA/E2 implant, which probably are uniform over a range of marbling scores. The difference in percentage Choice was the result of discriminate scoring near the separation point. Implant treatment effects on carcass characteristics generally agree with the increased longissimus muscle area and decreased fat measurements usually observed with E2 implants (Preston, 1987) and the lower marbling score and fat measures previously reported for TBA (Trenkle, 1987) . Implanting with TBA in addition to E2 in the present experiment resulted in increased (P < .05) longissimus muscle area and a numeric decrease in percentage Choice compared with E2 alone. Using five steers per treatment, Hunt et al. (1991) detected no differences in marbling score in steers implanted with TBA/E2 vs unimplanted steers.
The incidence of implant site infection was low (1 to 4 % ) and occurred most frequently in steers that received 140/0, 80116, or 140/28 treatments. When ADG of steers with implant site infections was compared to the ADG of their pens, performance was not different (P > .21. Liver abscess incidence was 46 and 9 % for the Colorado and Texas locations, respectively, and was not related to implant treatment (P > 2).
Carrier Experiment
Steer performance data for d 0 to 70 and d 0 to slaughter are shown in Table 5 . The F-values had probabilities < .05 for all variables. There were no Grandadam et al. (19751, Trenkel (19871, and Bartle et al. (1988) . response to SS reimplantation continued to increase with time, whereas TBA/E2 combinations had a large, early response and then reached a plateau. The trend for a n early advantage of TBA/ E2 combinations over S S is similar to results reported by Heitzeman et al. (19811. This experimental design excludes determination of the effectiveness of the single S S implant.
Dry matter intake and feed efficiency results for 0 to 70 d reflected the data from d 0 to slaughter.
Although there was not (P > .2) a n interaction between implant treatment and location for ADG at 70 d, there was (P < .05) for feed efficiency. At two locations, feed efficiency was greater for TBA/ E2 treatments than for the S S treatment. At the Colorado location, feed efficiency for the S S treatment was equal to or greater than that for the TBA/E2 implants. XJpZMeans within a row without a common superscript differ P < ,051.
200 mg of progesterone + 20 mg of estradiol. for KPH and was used as the error term to evaluate treatment effects. At the Colorado and Nebraska locations, KPH for the implant treatments were similar and lower than for the control treatment (about 1.9 vs 2.0% and about 2.6 vs 2.8%, respectively). At the Texas location, KPH of the 140/20-LA treatment was greater than that of the control treatment (2.2 vs 2.0%1.
Longissimus muscle areas reflected the gain responses and were numerically greater for all implant treatments than for control (140/20-LA and SS-reimplant, P e .051. Longissimus muscle area for the 140/28-CH treatment tended to be less than for the other implant treatments. In contrast to Exp. 1, backfat thickness tended to be greater for the implant treatments than for control. The control steers had the highest marbling scores ( P e .051. Marbling score for the implant treatments were similar (P > .21 except for the 1401 28-LA treatment, which was lower ( P e .05) than the other implant treatments. Kidney-pelvic-heart fat was greater (P < .051 for the control and 1401 20-LA treatments than for the other implant treatments.
Implant site infection rate was 14.2, 5.6, and 15.0% at 35 d and 3.3, .6, and 6.4% at 70 d for Colorado, Nebraska, and Texas locations, respectively. In the Texas experiment, liver abscess incidence was 21% and was not related to implant treatment (P > 2).
Implications
Estradiol level (20 or 28 mg of estradiol with 140 mg of trenbolone acetate) and carrier (lactose or cholesterol) did not affect implant efficacy. In a dose-response experiment, the highest dosage (140/28) resulted in performance superior to estradiol alone. Although trenbolone acetate/estradiol combinations resulted in greater longissimus muscle area and decreased carcass marbling score compared with control, no statistical differences in carcass quality were found between estradiol alone and the trenbolone ace-
